Werewolf Therapeutics

Werewolf Therapeutics is an innovative biopharmaceutical company committed to developing therapeutic agents that stimulate the human immune system to treat cancer. We are leveraging our proprietary Predator platform to design conditionally activated molecules that stimulate both adaptive and innate immunity, with the aim of addressing the limitations of traditional pro-inflammatory immunotherapies.